- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04973709
Prevalence of Dementia and Delirium in Outpatient Clinics (DESTAN Trial)
October 23, 2022 updated by: Bilal Katipoglu, Gulhane Training and Research Hospital
Gulhane Training and Research Hospital
The aim of this study is to assess the prevalence and etiologic risk factors of delirium in outpatient geriatric patients and also hospitalized patients.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
This study aimed to investigate the frequency of delirium and examines the association between delirium and other possible risk factors and prognostic factors (dementia etc.)
Study Type
Observational
Enrollment (Anticipated)
714
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ankara, Turkey, 06670
- Recruiting
- Gulhane Training and Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Community-dwelling older adults (65 years and older)
Description
Inclusion Criteria:
- We included all 65 years older patients who evaluated according to a comprehensive geriatric assessment that is consistently performed during admission to the outpatients' clinic of the hospital.
Exclusion Criteria:
- Exclusion criteria were serious psychiatric disorders such as schizophrenia or major depression.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Delirium with dementia
Delirium was detected using the short form of the Confusion Assessment Method (CAM) both at admission and daily throughout the hospital stay.
Cognitive status was determined using the Mini-Mental State Exam, Clinical Dementia Rating (CDR).
Dementia was defined by a CDR score of 1.
The primary independent variable was a composite of delirium and dementia diagnosis, and we examined the overlap by categorizing the cases into four groups: no delirium or dementia, dementia alone, delirium alone, and DSD.
|
Participants enrolled in the Delirium group according to the CAM.
Participants enrolled in the Dementia group according to the CDR scores and MMSE scores and DSM4/5 criteria
|
Dementia without Delirium
Delirium was detected using the short form of the Confusion Assessment Method (CAM) both at admission and daily throughout the hospital stay.
Cognitive status was determined using the Mini-Mental State Exam, Clinical Dementia Rating (CDR).
Dementia was defined by a CDR score of 1.
The primary independent variable was a composite of delirium and dementia diagnosis, and we examined the overlap by categorizing the cases into four groups: no delirium or dementia, dementia alone, delirium alone, and DSD.
|
Participants enrolled in the Dementia group according to the CDR scores and MMSE scores and DSM4/5 criteria
|
Delirium without Dementia
Delirium was detected using the short form of the Confusion Assessment Method (CAM) both at admission and daily throughout the hospital stay.
Cognitive status was determined using the Mini-Mental State Exam, Clinical Dementia Rating (CDR).
Dementia was defined by a CDR score of 1.
The primary independent variable was a composite of delirium and dementia diagnosis, and we examined the overlap by categorizing the cases into four groups: no delirium or dementia, dementia alone, delirium alone, and DSD.
|
Participants enrolled in the Delirium group according to the CAM.
|
No dementia, No delirium
Delirium was detected using the short form of the Confusion Assessment Method (CAM) both at admission and daily throughout the hospital stay.
Cognitive status was determined using the Mini-Mental State Exam, Clinical Dementia Rating (CDR).
Dementia was defined by a CDR score of 1.
The primary independent variable was a composite of delirium and dementia diagnosis, and we examined the overlap by categorizing the cases into four groups: no delirium or dementia, dementia alone, delirium alone, and DSD.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
frequency of Mortality
Time Frame: 1 year fellow-up
|
1st year mortality according to the electronic national data base
|
1 year fellow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Mehmet Naharcı, Saglik Bilimleri Universitesi
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 5, 2021
Primary Completion (Actual)
October 5, 2022
Study Completion (Anticipated)
November 11, 2025
Study Registration Dates
First Submitted
July 4, 2021
First Submitted That Met QC Criteria
July 21, 2021
First Posted (Actual)
July 22, 2021
Study Record Updates
Last Update Posted (Actual)
October 25, 2022
Last Update Submitted That Met QC Criteria
October 23, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-382
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Delirium in Old Age
-
University of Modena and Reggio EmiliaUnknownDementia | Cataract | Cataract Senile | Mild Cognitive Impairment | Post-Op Complication | Delirium in Old Age | Delirium Confusional State | Cataract in Old AgeItaly
-
Ain Shams UniversityCompletedDelirium in Old AgeEgypt
-
Aalborg University HospitalCompleted
-
Bnai Zion Medical CenterCompleted
-
Assiut UniversityNot yet recruitingDelirium in Old Age
-
Duke UniversityMerck Sharp & Dohme LLCRecruitingDelirium in Old AgeUnited States
-
Menoufia UniversityCompleted
-
Seoul National University HospitalCompleted
-
Academisch Medisch Centrum - Universiteit van Amsterdam...ZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedDelirium in Old Age
-
University of Alabama at BirminghamCompleted
Clinical Trials on Confussion assessment method (CAM)
-
NYU Langone HealthNot yet recruiting
-
Istanbul UniversityCompletedPostoperative DeliriumTurkey
-
Keimyung University Dongsan Medical CenterRecruitingDelirium | Dementia | Mild Cognitive ImpairmentKorea, Republic of
-
Kessler FoundationNYU Langone HealthCompleted
-
Ospedale San DonatoCompleted
-
Taipei Veterans General Hospital, TaiwanRecruitingPostoperative Delirium | Postoperative Cognitive Dysfunction | General Anesthesia | Ischemic Stroke, Acute | Total Intravenous Anesthesia | ThrombectomyTaiwan
-
Samara State Medical UniversityActive, not recruitingSchool Readiness | School AdaptationRussian Federation
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedDepression | Breast Cancer | Fatigue | Psychosocial Effects of Cancer and Its Treatment | Weight ChangesUnited States